TABLE 3

Correlation Between Percentage of Change in Corrected SUVmax of Primary Malignancy and Percentage of Reduction in Tumor Burden on Pathology After Neoadjuvant Therapy

Change/reduction
ParameterSUVmaxPathologyρP
Median−99%−92%0.79<0.001
Range−33% to −100%−10% to −100%